Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Wave Life Sciences to Present at Upcoming Investor Conferences
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
Tickers WVE
IPDN Welcomes His Highness Shaikh Ali Sultan Al Nuaimi of the UAE Royal Family as Independent Director
From Professional Diversity Network, Inc.
Via GlobeNewswire
Tickers IPDN
ALX Oncology Reports Third Quarter 2025 Financial Results and Provides Corporate Update
From ALX Oncology
Via GlobeNewswire
Tickers ALXO
Legacy Housing Announces Agreement to Purchase Assets of AmeriCasa Solutions, LLC and Addition of New Senior Management
From Legacy Housing Corporation
Via GlobeNewswire
Tickers LEGH
Treace Announces Participation in Two Upcoming Investor Conferences
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Tickers TMCI
Celldex to Present at Upcoming Investor Conferences
From Celldex Therapeutics, Inc.
Via GlobeNewswire
Tickers CLDX
Conduent Reports Third Quarter 2025 Financial Results
From Conduent Business Services, LLC
Via GlobeNewswire
Tickers CNDT
Press Release: ACAAI: Sanofi and Regeneron’s Dupixent pivotal study met all primary and secondary endpoints, reducing signs and symptoms of allergic fungal rhinosinusitis; sBLA accepted for FDA priority review
From Sanofi Winthrop Industrie
Via GlobeNewswire
Immunocore presents Phase 1 data for hepatitis B candidate at AASLD’s The Liver Meeting
From Immunocore Holdings plc
Via GlobeNewswire
Tickers IMCR
AirJoule Technologies Schedules Release of Third Quarter 2025 Results and Conference Call
From AirJoule Technologies Corporation
Via GlobeNewswire
Tickers AIRJ
Atea Pharmaceuticals Presents New Data Supporting the Fixed-Dose Combination of Bemnifosbuvir and Ruzasvir as a Potential Best-in-Class Regimen for Treatment of Hepatitis C Virus Infection at The Liver Meeting® 2025
From Atea Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers AVIR
Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences
From Centessa Pharmaceuticals plc
Via GlobeNewswire
Tickers CNTA
Dycom Industries, Inc. to Host Fiscal 2026 Third Quarter Results Conference Call
From Dycom Industries Inc
Via GlobeNewswire
Tickers DY
Dupixent® (dupilumab) Pivotal Trial Met All Primary and Secondary Endpoints, Reducing Signs and Symptoms of Allergic Fungal Rhinosinusitis (AFRS); sBLA Accepted for FDA Priority Review
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers REGN
Assembly Biosciences Presents Positive Phase 1b Data for Next-Generation Capsid Assembly Modulator ABI-4334 at AASLD The Liver Meeting®
From Assembly Biosciences, Inc.
Via GlobeNewswire
Tickers ASMB
ESET to aid MSPs by integrating with ConnectWise Asio
From ESET
Via GlobeNewswire
Vor Bio to Participate in Upcoming Investor Conferences
From Vor Biopharma
Via GlobeNewswire
Tickers VOR
Rivus Pharmaceuticals Announces New Data from Phase 2 M-ACCEL Trial of HU6 in MASH in Late-Breaker Oral Presentation at AASLD The Liver Meeting® 2025
From Rivus Pharmaceuticals, Inc.
Via GlobeNewswire
illumin Reports Third Quarter 2025 Financial Results
From illumin
Via GlobeNewswire
Tickers ILLMF TSX:ILLM
Barrick Completes Sale of Alturas Project
From BARRICK MINING CORPORATION
Via GlobeNewswire
Tickers B TSX:ABX
Copyseeker Pioneers Visual Search Integration in AI with Model Context Protocol Launch
From MB AI Brothers
Via GlobeNewswire
Barinthus Bio Reports Third Quarter 2025 Financial Results and Updates on Corporate Developments
From Barinthus Biotherapeutics
Via GlobeNewswire
Tickers BRNS
Abeona Therapeutics® Announces Date of Third Quarter Financial Results and Upcoming Investor Conference Participation
From Abeona Therapeutics Inc.
Via GlobeNewswire
Tickers ABEO
Rhythm Pharmaceuticals Announces FDA Extension of Review Period for IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity
From Rhythm Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers RYTM
Context Therapeutics Highlights CT-95 and CT-202 Programs at 2025 SITC Annual Meeting
From Context Therapeutics Inc.
Via GlobeNewswire
Tickers CNTX
Onex Reports Third Quarter 2025 Results
From ONEX Corporation
Via GlobeNewswire
Tickers TSX:ONEX
Quantum Biopharma Reports Strong Third Quarter Results Maintaining ‘No Going Concern’ Status with Cash Runway Extending Beyond March 2027, and $572,000 USD Gains in Crypto Portfolio
From Quantum BioPharma
Via GlobeNewswire
Tickers CSE:QNTM QNTM
Akero Therapeutics Presents New Analyses from Phase 2b SYMMETRY and HARMONY Trials of Efruxifermin at 76th Annual AASLD The Liver Meeting® 2025
From Akero Therapeutics Inc.
Via GlobeNewswire
Tickers AKRO
RYTHM, Inc. Reports Third Quarter 2025 Results
From RYTHM, Inc.
Via GlobeNewswire
Tickers RYM
GenVivo to Present Phase 1 Trial Results for GEN2, A Personalizing Systemic Cancer Immunotherapy, at the 2025 Society for Immunotherapy of Cancer (SITC) Annual Meeting
From GenVivo, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.